Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:54:30.387Z.
Calculation as of: 2026-10-06T19:54:30.387Z.
Quote observation: 2026-10-06T19:50:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5137b4856deab08b1171b62dbd6f0c7b956cbbc758e96459f42c43e497148cec
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-04.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.11B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.11B
EV/FCF Ratio
13.82x
TTM Avg
18.28x
3Y Avg
18.51x
5Y Avg
20.32x
Market Cap
$2.17B
EV/FCF Ratio
N/A
TTM Avg
7.18x
3Y Avg
10.07x
5Y Avg
14.95x
Market Cap
$2.07B
EV/FCF Ratio
N/A
TTM Avg
5.92x
3Y Avg
5.59x
5Y Avg
5.59x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | $2.13B | N/A | N/A | N/A | N/A |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | N/A | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.16B | N/A | N/A | N/A | N/A |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 13.82x | 18.28x | 18.51x | 20.32x |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | N/A | 7.18x | 10.07x | 14.95x |
| Vera Therapeutics, Inc. (VERA)vs › | $2.10B | N/A | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.07B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.07B | N/A | 5.92x | 5.59x | 5.59x |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-05-04 | 131.37x |
| 2026-05-01 | 126.57x |
| 2026-04-30 | 121.87x |
| 2026-04-29 | 121.89x |
| 2026-04-28 | 127.87x |
| 2026-04-27 | 128.06x |
| 2026-04-24 | 132.51x |
| 2026-04-23 | 128.19x |
| 2026-04-22 | 134.96x |
| 2026-04-21 | 131.70x |
| 2026-04-20 | 134.73x |
| 2026-04-17 | 127.66x |
| 2026-04-16 | 126.64x |
| 2026-04-15 | 130.49x |
| 2026-04-14 | 129.36x |
| 2026-04-13 | 118.27x |
| 2026-04-10 | 115.71x |
| 2026-04-09 | 116.52x |
| 2026-04-08 | 126.96x |
| 2026-04-07 | 129.41x |
| 2026-04-06 | 128.89x |
| 2026-04-02 | 128.11x |
| 2026-04-01 | 126.83x |
| 2026-03-31 | 124.38x |
| 2026-03-30 | 115.69x |
| 2026-03-27 | 110.94x |
| 2026-03-26 | 118.97x |
| 2026-03-25 | 129.53x |
| 2026-03-24 | 132.77x |
| 2026-03-23 | 139.31x |
| 2026-03-20 | 134.98x |
| 2026-03-19 | 140.93x |
| 2026-03-18 | 136.58x |
| 2026-03-17 | 145.65x |
| 2026-03-16 | 146.80x |
| 2026-03-13 | 149.95x |
| 2026-03-12 | 148.19x |
| 2026-03-11 | 163.75x |
| 2026-03-10 | 170.80x |
| 2026-03-09 | 181.49x |
| 2026-03-06 | 169.42x |
| 2026-03-05 | 157.90x |
| 2026-03-04 | 153.13x |
| 2026-03-03 | 148.42x |
| 2026-03-02 | 143.20x |
| 2026-02-27 | 153.59x |
| 2026-02-26 | 156.74x |
| 2026-02-25 | 152.06x |
| 2026-02-24 | 155.45x |
| 2026-02-23 | 163.25x |
| 2026-02-20 | 153.91x |
| 2026-02-19 | 169.96x |
| 2026-02-18 | 172.49x |
| 2026-02-17 | 170.61x |
| 2026-02-13 | 168.97x |
| 2026-02-12 | 169.94x |
| 2026-02-11 | 171.37x |
| 2026-02-10 | 177.59x |
| 2026-02-09 | 171.00x |
| 2026-02-06 | 158.06x |
| 2026-02-05 | 157.67x |
| 2026-02-04 | 160.03x |
| 2026-02-03 | 178.43x |
| 2026-02-02 | 185.47x |
| 2026-01-30 | 180.35x |
| 2026-01-29 | 183.89x |
| 2026-01-28 | 178.54x |
| 2026-01-27 | 179.88x |
| 2026-01-26 | 196.40x |
| 2026-01-23 | 189.83x |
| 2026-01-22 | 190.81x |
| 2026-01-21 | 187.39x |
| 2026-01-20 | 186.72x |
| 2026-01-16 | 202.36x |
| 2026-01-15 | 204.59x |
| 2026-01-14 | 195.80x |
| 2026-01-13 | 205.63x |
| 2026-01-12 | 223.14x |
| 2026-01-09 | 253.19x |
| 2026-01-08 | 257.08x |
| 2026-01-07 | 255.37x |
| 2026-01-06 | 253.97x |
| 2026-01-05 | 245.96x |
| 2026-01-02 | 247.45x |
| 2025-12-31 | 243.28x |
| 2025-12-30 | 239.45x |
| 2025-12-29 | 241.94x |
| 2025-12-26 | 250.23x |
| 2025-12-24 | 254.51x |
| 2025-12-23 | 253.13x |
| 2025-12-22 | 262.11x |
| 2025-12-19 | 262.61x |
| 2025-12-18 | 254.94x |
| 2025-12-17 | 254.23x |
| 2025-12-16 | 264.99x |
| 2025-12-15 | 281.55x |
| 2025-12-12 | 283.22x |
| 2025-12-11 | 290.41x |
| 2025-12-10 | 296.37x |
| 2025-12-09 | 300.56x |
| 2025-12-08 | 298.66x |
| 2025-12-05 | 297.10x |
| 2025-12-04 | 302.66x |
| 2025-12-03 | 299.74x |
| 2025-12-02 | 300.15x |
| 2025-12-01 | 305.75x |
| 2025-11-28 | 311.97x |
| 2025-11-26 | 309.48x |
| 2025-11-25 | 313.03x |
| 2025-11-24 | 301.04x |
| 2025-11-21 | 273.99x |
| 2025-11-20 | 250.79x |
| 2025-11-19 | 249.93x |
| 2025-11-18 | 237.44x |
| 2025-11-17 | 242.33x |
| 2025-11-14 | 239.56x |
| 2025-11-13 | 243.82x |
| 2025-11-12 | 255.16x |
| 2025-11-11 | 261.62x |
| 2025-11-10 | 266.67x |
| 2025-11-07 | 261.29x |
| 2025-11-06 | 259.37x |
| 2025-11-05 | 255.96x |
| 2025-11-04 | 260.84x |
| 2025-11-03 | 258.63x |
| 2025-10-31 | 256.04x |
| 2025-10-30 | 245.96x |
| 2025-10-29 | 246.45x |
| 2025-10-28 | 4976.55x |
| 2025-10-27 | 4732.43x |
| 2025-10-24 | 4668.26x |
| 2025-10-23 | 4532.04x |
| 2025-10-22 | 4386.49x |
| 2025-10-21 | 4413.74x |
| 2025-10-20 | 4602.30x |
| 2025-10-17 | 4383.98x |
| 2025-10-16 | 4293.65x |
| 2025-10-15 | 4239.51x |
| 2025-10-14 | 4425.93x |
| 2025-10-13 | 4381.47x |
| 2025-10-10 | 4411.94x |
| 2025-10-09 | 4594.41x |
| 2025-10-08 | 4446.72x |
| 2025-10-07 | 4377.53x |
| 2025-10-06 | 4357.10x |
| 2025-10-03 | 4287.91x |
| 2025-10-02 | 4256.00x |
| 2025-10-01 | 4115.12x |
| 2025-09-30 | 3910.79x |
| 2025-09-29 | 4132.69x |
| 2025-09-26 | 4250.27x |
| 2025-09-25 | 4097.91x |
| 2025-09-24 | 4143.08x |
| 2025-09-23 | 4402.98x |
| 2025-09-22 | 4701.24x |
| 2025-09-19 | 4694.43x |
| 2025-09-18 | 4734.22x |
| 2025-09-17 | 4634.20x |
| 2025-09-16 | 4399.40x |
| 2025-09-15 | 4423.42x |
| 2025-09-12 | 4491.89x |
| 2025-09-11 | 4561.43x |
| 2025-09-10 | 4465.00x |
| 2025-09-09 | 4564.30x |
| 2025-09-08 | 4684.75x |
| 2025-09-05 | 4799.82x |
| 2025-09-04 | 4718.09x |
| 2025-09-03 | 4609.11x |
| 2025-09-02 | 4643.52x |
| 2025-08-29 | 4690.48x |
| 2025-08-28 | 4672.92x |
| 2025-08-27 | 4679.73x |
| 2025-08-26 | 4574.34x |
| 2025-08-25 | 4417.32x |
| 2025-08-22 | 4661.09x |
| 2025-08-21 | 4376.10x |
| 2025-08-20 | 4360.68x |
| 2025-08-19 | 4373.59x |
| 2025-08-18 | 4561.79x |
| 2025-08-15 | 4578.28x |
| 2025-08-14 | 4453.53x |
| 2025-08-13 | 4461.77x |
| 2025-08-12 | 4221.59x |
| 2025-08-11 | 4011.16x |
| 2025-08-08 | 3817.22x |
| 2025-08-07 | 3846.62x |
| 2025-08-06 | 3843.03x |
| 2025-08-05 | 3871.71x |
| 2025-08-04 | 3932.65x |
| 2025-08-01 | 3690.68x |
| 2025-07-31 | 3703.23x |
| 2025-07-30 | 3759.15x |
